Search results
Galapagos (AMS:GLPG) shareholders have endured a 82% loss from investing in the stock three years...
Simply Wall St. via Yahoo Finance· 1 year agoEvery investor on earth makes bad calls sometimes. But really bad investments should be rare. So...
Strong week for Galapagos (AMS:GLPG) shareholders doesn't alleviate pain of three-year loss
Simply Wall St. via Yahoo Finance· 2 years agoEvery investor on earth makes bad calls sometimes. But really big losses can really drag down an...
Best Momentum Stocks to Buy for December 13th
Zacks via Yahoo Finance· 6 months agoHere are three stocks with buy rank and strong momentum characteristics for investors to consider today, December 13th: Galapagos NV GLPG: This...
Regeneron's (REGN) Lymphoma Candidate Rejected by the FDA
Zacks via Yahoo Finance· 3 months agoRegeneron Pharmaceuticals, Inc. REGN suffered a setback as the FDA issued Complete Response Letters...
Novo Nordisk (NVO) Gets Positive CHMP Opinion for Insulin Icodec
Zacks via Yahoo Finance· 3 months agoNovo Nordisk NVO announced that the European Medicines Agency’s Committee for Medicinal Products for...
Fate Therapeutics (FATE) Surges 86.4% YTD on Pipeline Progress
Zacks via Yahoo Finance· 3 months agoFate Therapeutics’ FATE shares have surged 86.4% year to date compared with the industry’s growth of...
Avalo Therapeutics (AVTX) Surges 270% in a Week: Here's Why
Zacks via Yahoo Finance· 3 months agoAvalo (AVTX) surges on adding a new pipeline drug, which has its origins at Eli Lilly. Alongside the...
Bayer's (BAYRY) Elinzanetant Meets Goals in Third Phase III Study
Zacks via Yahoo Finance· 3 months agoBayer's (BAYRY) pipeline candidate, elinzanetant, achieves primary and secondary goals in late-stage...
Sarepta (SRPT) Seeks Label Expansion for DMD Gene Therapy
Zacks via Yahoo Finance· 6 months agoSarepta (SRPT) files a supplement with the FDA seeking to expand its recently-approved gene therapy...
Moderna (MRNA) Soars on Upbeat Data From Cancer Therapy Study
Zacks via Yahoo Finance· 6 months agoThree-year follow up data from a mid-stage study shows that treatment with Moderna (MRNA)/Merck's...